Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate for Prevention of Osteoporosis After Spinal Cord Injury
NCT00150696Phase 3Completed
- Sponsor
- Toronto Rehabilitation Institute
- Start
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risedronate in osteoporosis, sponsored by Toronto Rehabilitation Institute. Started Feb 2000; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00150696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150696.